US STOCKS-Bed, Bath & Beyond, Merrimack Pharma surge in premarket

NEW YORK, Sept 24 (Reuters) - Merrimack Pharmaceuticals shares were surging in premarket trade, up 24.5 percent to $8.95 after the company said it reached a deal to develop and market Merrimack's pancreatic cancer drug outside the U.S. with Baxter International.